Tokyo, Japan and Chicago, US (March 2nd, 2020) – GE Healthcare (Head Office: Chicago, US) today completed the transfer of ownership of its four diagnostic imaging agents in Japan from Daiichi Sankyo Company, Limited (Head Office: Chuo-ku Tokyo; Daiichi Sankyo).
Effective immediately, the four imaging agents, previously managed by Daiichi Sankyo, will be owned and managed by GE Healthcare Pharma Limited*, which will now be responsible for all aspects of their commercialization for Japanese hospitals and clinics.